29th Annual Max R. Gaspar, MD Symposium: Zebras, Unicorns, and Black Swans: Beyond Everyday Vascular Surgery

Thursday, September 4, 2025, 7:00 AM - 4:05 PM, Westin Pasadena, Pasadena, CA


AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

1. • Identify advanced complex endovascular treatments available to patients through symbiotic relationships between cardiothoracic surgery, vascular surgery, and specialist partners.
2. • Discuss the importance of integrated care pathways with affiliated health professionals in the long-term maintenance of remission in chronic limb threatening ischemia
3. • Assess efforts toward prevention of amputation with targeted interventions informed by social science approaches.
4. • Integrate knowledge from basic sciences in the understanding of aortic pathology and treatment.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 6.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy
Cancellations must be received by the USC Office of CME by email only by ________ by 12:00 pm PDT for a refund to be issued. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.